We are developing the first universal vaccine against the SARS coronavirus. Our vaccine is designed to protect not only against SARS-CoV-2 (COVID-19), the virus responsible of the current pandemic, but also against other highly pathogenic SARS coronaviruses of the future.
Phylex Biosciences
is a next-generation vaccine company uniquely located at
the crossroads of information technology and biotechnology.
the crossroads of information technology and biotechnology.